Competitive + Benefits : The Medicines and Healthcare products Regulatory Agency (MHRA): A 3-year full-time PhD studentship is available in the Division... Agency HQ, London, United Kingdom

Competitive Salary: EMBL: Bioinformatician Location: EMBL- Cambridge, Cambridgeshire, England

Funding Opportunity RFA-AI-20-015 from the NIH Guide for Grants and Contracts. The objective of this Funding Opportunity Announcement (FOA) is to pair Bioengineers and Immunologists to leverage emerging innovative knowledge in physical and computational science for the design and development of an HIV-1 vaccine.

The job also expects that the candidate devote 50% of time to contribute to team science across the university for collaborative research through genomic data…
From West Virginia University - Sun, 08 Mar 2020 10:09:12 GMT - View all Morgantown, WV jobs

The job also expects that the candidate devote 50% of time to contribute to team science across the university for collaborative research through genomic data…
From West Virginia University - Sun, 08 Mar 2020 10:09:12 GMT - View all Morgantown, WV jobs

The job also expects that the candidate devote 50% of time to contribute to team science across the university for collaborative research through genomic data…
From West Virginia University - Sun, 08 Mar 2020 10:09:12 GMT - View all Morgantown, WV jobs

Leads the BDAU team in, or, if necessary, directly performs bioinformatics analysis on research or clinical samples to meet deadlines defined in SoW.
From Medical College of Wisconsin - Sat, 07 Mar 2020 09:07:29 GMT - View all Milwaukee, WI jobs

Adapts bioinformatics tools, visualization packages, and annotation resources for research projects to independently and accurately perform research analysis –…
From Medical College of Wisconsin - Sat, 07 Mar 2020 09:07:14 GMT - View all Milwaukee, WI jobs

Funding Opportunity RFA-AI-20-016 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support basic, translational, and clinical research to improve the understanding of the effector or immunoregulatory potentials of NK cells for HIV prevention, control and/or eradication.

Funding Opportunity RFA-CA-20-033 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required.

Funding Opportunity RFA-AI-20-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to invite applications for innovative clinical, and preclinical/translational research to develop therapeutic vaccine strategies to improve treatment outcomes of active tuberculosis (TB) in the presence or absence of HIV co-infection.

Funding Opportunity PAS-20-121 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative basic, translational, and clinical research to identify and address the challenges to achieving hepatitis B virus (HBV) cure in the presence of human immunodeficiency virus (HIV.

Notice NOT-HL-20-753 from the NIH Guide for Grants and Contracts

Notice NOT-DC-20-002 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AR-21-003 from the NIH Guide for Grants and Contracts. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for the NIAMS Resource-based Centers Program (P30) for skin biology and diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on skin biology and diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research within the NIAMS mission.

£32,235 - £35,709 per annum: Animal and Plant Health Agency: The Animal and Plant Health Agency (APHA) is an executive agency of the Department for Environment, Food & Rural Affairs..... New Haw, Addlestone

Funding Opportunity PAR-20-125 from the NIH Guide for Grants and Contracts. The National Institute of General Medical Sciences, in conjunction with the Institutes/Centers of the National Institutes of Health (NIH) listed above in the "Components of Participating Organizations" section and the Indian Health Service (IHS), invites applications from federally recognized Tribes and Tribal organizations for the Native American Research Centers for Health (NARCH) initiative. The objective of the NARCH initiative is to support opportunities for conducting research and career enhancement opportunities to meet health needs prioritized by American Indian/Alaska Native (AI/AN) communities. The NARCH initiative also supports infrastructure and capacity building to ensure enable research sustainability and increased competitiveness of the Centers in their efforts of facilitating strong research environments relevant to the health needs of AI/AN communities.

Funding Opportunity PAR-20-123 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of AIDS Research (OAR) [https://www.oar.nih.gov/hiv-policy-and-research/research-priorities] in the areas of hearing, balance, taste, smell, voice, speech, and language.

Funding Opportunity PAR-20-127 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research within the scientific mission areas of the National Institute on Deafness and Other Communications Disorders (NIDCD). Applications should address high priority HIV/AIDS research outlined by the NIH Office of AIDS Research (OAR) [https://www.oar.nih.gov/hiv-policy-and-research/research-priorities] in the areas of hearing, balance, taste, smell, voice, speech, and language.

Funding Opportunity RFA-RM-20-010 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this Common Fund R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Curriculum or Methods Development in cryoelectron microscopy (cryoEM) and cryoelectron tomography (cryoET) for biology research.